Study on The Implementation of Good Distribution Practices (GDP) in The Indian Pharmaceutical Supply Chain

Abstract

The pharmaceutical supply chain in India plays a critical role in ensuring the safe, effective, and timely delivery of medicines to patients. Good Distribution Practices (GDP) are essential regulatory frameworks designed to maintain the quality and integrity of pharmaceutical products during storage, transportation, and distribution. This study investigates the implementation of GDP in the Indian pharmaceutical supply chain, highlighting key challenges, compliance gaps, and best practices. Data were collected through a combination of literature review, regulatory guidelines analysis, and interviews with industry stakeholders, including manufacturers, distributors, and regulatory authorities. The findings indicate that while leading pharmaceutical companies in India have established robust GDP-compliant processes, small and medium-sized enterprises (SMEs) often face infrastructural, financial, and training-related barriers to full compliance. Common challenges include temperature-controlled transportation, documentation management, risk-based distribution, and regulatory awareness. The study emphasizes the need for stronger regulatory enforcement, continuous workforce training, adoption of technology-enabled tracking systems, and collaborative industry initiatives to enhance GDP compliance. Implementing effective GDP not only ensures product quality and patient safety but also strengthens the credibility of the Indian pharmaceutical sector in global markets.